John Calleja Melbourne Pathology Services. Gold Coast 20th Sept 2013
|
|
- Sybil Robbins
- 6 years ago
- Views:
Transcription
1 Sources of Targets John Calleja Melbourne Pathology Services AACB QC Satellite Meeting Gold Coast 20th Sept 2013
2 Content Definitions Selecting QC Materials Various Sources of Targets How effective they are / Pros & Cons How many Data Points if set your own What do we do when you have multiple instruments/methods t th Setting QC Limits What do we do when we have a Shift Summary & References J.Calleja - Melb. Path. - Sept
3 1. Definitions. J.Calleja - Melb. Path. - Sept
4 1. Definitions: Target A goal we are aiming to achieve. Target Value A value assigned to a reference material (eg) QC Material that we should aim to achieve when the material is analysed routinely. This provides us with a stable reference point against which to measure the stability of our process, over time. Allowable Limits are usually assigned around a Target Value, to denote an acceptable range we should aim to achieve. Target Material A QC Material with desirable attributes & characteristics. J.Calleja - Melb. Path. - Sept
5 2. Selecting QC Materials. J.Calleja - Melb. Path. - Sept
6 2.1 Selecting a Suitable QC material. - General Requirements: 1. Of similar matrix to the usual sample being measured. 2. Materials should have suitable analyte concentrations, which are a. Within the Analytical Measuring Range. b. At critical Clinical Decision Levels.. Normal & Pathological 3. Stable on Reconstitution / Opening. ( Bili, CK, ALP, HCO3 ) 4. Long Shelf Life. 5. Little Vial to Vial variation. 6. Suitable Vial size. - Given Consumption Rate / Stability 7. Safe for General Handling... HIV / HepB / Hep C ve 8. Come from a Reputable Manufacturer/ Distributor. - Prompt / Reliable Customer Service / Product Support 9. Economical... $$$$'s ( Standing Order..configurable ) 6
7 2.2 Selecting QC Materials Requirements/Eval Template General Demographics Analytes Analyser Measuring Range Patient Reference Interval Current QC Levs Level Profiling Results Appraisals J.Calleja - Melb. Path. - Sept
8 3. Sources of Targets. J.Calleja - Melb. Path. - Sept
9 3. Sources of Targets QC Package Inserts Consensus Values from a centralised QC DataBase eg. BioRad s QC-Net, Unity Real Time Set by Your Own Laboratory J.Calleja - Melb. Path. - Sept
10 3.1 Manufacturer QC Kit Insert Values An example of a commercially available QC Material This is an Assayed Material -> it comes with Assigned Values. J.Calleja - Melb. Path. - Sept
11 3.1 Manufacturer QC Kit Insert Values The insert states instrument / method specific values! FT4: +/- 3sd QC Limits pmol/l pmol/l pmol/l J.Calleja - Melb. Path. - Sept
12 3.1 Manufacturer QC Kit Insert Values PSA Abbott Architect Can t just use someone else s targets! Values differ between different Instruments & Methods! Disadv: Your Method Instrument may not be Listed! Vitros ECi Siemens Vista Roche e602 J.Calleja - Melb. Path. - Sept
13 3.2 Consensus Values from QC Database Labs using 3 rd Party QC Packages Mthly Uploads of labs QC Data Internet Log-in to QC-Net & Download Reports Bio-Rad Participant Lab BioRad complies the data from all participating labs & produces method specific summary stats! QC-Net Data- base! J.Calleja - Melb. Path. - Sept
14 3.2 Consensus Values from QC Database World-Wide Wide Report Method Specific Consensus Values for QC Lot! DisAdv: Lot must already be in use by other participants to be of use. J.Calleja - Melb. Path. - Sept
15 3.3 Establish Your Own Target Values ** Establish by - Running the QC Material lseveral times.. For all relevant tests.. On all relevant Instruments / Modules / Channels.. Over a number of days / runs / calibrations /operators.... Thereby exposing the process to as many possible sources of variation, as is practical. - Run the material passively, in parallel to your Existing QCs. - When sufficient Data has been accumulated; - Calculate Mean & SD - Remove any Outliers (Exclude values > 3sd) - Re-Determine the Mean - Set this as the... Target Value J.Calleja - Melb. Path. - Sept
16 3.3.1 How Many Data Points? ** Statistic: Standard Error of the Mean (SEM). This statistic ti ti gives us the Amount of Error, associated with a given Target Value.. Given the - SD of the data set & - the Number of QC observations. S where S = S.D. SEM = --- n = no. of control n observations. The Accuracy of a Target Value.. Increases... with an Increasing Number of Observations. J.Calleja - Melb. Path. - Sept
17 How Many Data Points? - Standard Error of the Mean (SEM) No. of Results 60...No Appreciable 50 Decrease in SEM for n > n = n = 20 n= Error of the Mean ( Arbitrary Units ) J.Calleja - Melb. Path. - Sept
18 4. Issues Relating to various Sources of Targets. J.Calleja - Melb. Path. - Sept
19 4.1 How reliable are Package Insert Values? J.Calleja - Melb. Path. - Sept
20 4.1 Reliability of Manufacturer Kit Insert Values - How appropriate are the targets & ranges provided? The values are.. Mean Values with +/- 3sd Ranges! They.. recommended that each laboratory establish their own acceptable ranges J.Calleja - Melb. Path. - Sept
21 4.1 Reliability of Manufacturer Kit Insert Values - How appropriate are the targets & ranges provided? The values are.. Mean Values with +/- 3sd Ranges! Values were produced by the various Inst. Manufacturers & Independent laboratories They.. recommended that each laboratory establish its own acceptable ranges Disclaimer.. Variations between lab ranges & established ranges, may be caused by.. Differences in; technique, reagents, instruments & by manufacturer test modifications J.Calleja - Melb. Path. - Sept
22 4.1 Reliability of Manufacturer Kit Insert Values - How appropriate are the targets provided? FT4 Reasonable! MPS Assigned Values Consensus Values Kit Insert FT4: Derived +/- 2sd QC Limits sd=0.62, cv=7% sd=2, cv=7% sd=4.66, cv=7% J.Calleja - Melb. Path. - Sept
23 4.1 Reliability of Manufacturer Kit Insert Values - How appropriate are the targets provided? Vit B12 Reasonable! MPS Assigned Values Consensus Values Kit Insert B12: Derived +/- 2sd QC Limits sd=30, cv=12.9% sd=38.5, cv=10% sd=53, cv=10% J.Calleja - Melb. Path. - Sept
24 4.1 Reliability of Manufacturer Kit Insert Values - However, Caution.. if you Don t Set Your Own identical sets of data but with different target values 1. Target= qc data 9 low lim target high lim 2. Target= qc data 9 low lim target high lim Inappropriately p set Targets will cause QC Rules to fail unnecessarily! J.Calleja - Melb. Path. - Sept
25 4.1 Reliability of Manufacturer Kit Insert Values - How appropriate are the ranges provided? FT4: +/- 3sd QC Limits pmol/l pmol/L pmol/l Derive, SD & CV -> sd=0.66 -> CV=7% -> sd= > CV=7% -> sd=4.68 -> CV=7% Compare to Biol. Goals CV i (FT4) = 7.6% Min: 0.75CV i = 5.7% Des: 0.5CV i = 3.8% Opt: 0.25CV i = 1.9% Ranges Given are significantly wider than the FT4 Biological Goals.. => May not be appropriate from Clinical Needs Basis! J.Calleja - Melb. Path. - Sept
26 4.2 What if you have Multiple Instruments measuring the same test? J.Calleja - Melb. Path. - Sept
27 4.2 Eg. MPS- Parallel Analysis on 18 IA Channels. Multiple Channels/ Instruments MPS: 2 Automation Lines 6 ISE Channels 10 Chem. Channels 1 Special Chem. 4 x e602 IA analysers 4 x e602 IA analysers 2 x ISE + 2 x c701 Chem. analysers 2 x ISE + 2 x c701 Chem. analysers Lots of Parallel Analysis Occuring! - ISE.. on 6 channels - Gen. Chem. on 3 chnls. - most IA on at least 2 chnls. - TSH on 5 chnls. - PSA, B12 on 4 chnls J.Calleja - Melb. Path. - Sept x ISE + c701 + c502 + e602 analysers + 1 Stat Line 27
28 4.2 Eg. MPS- Parallel Analysis on Multiple Channels/ Instruments Regional Labs 5 x Integra 400s 4 x Integra 800s J.Calleja - Melb. Path. - Sept
29 .. So should we ; Assign specific targets for every instrument t / channel measuring the same test or.. Use a common target? J.Calleja - Melb. Path. - Sept
30 Same Targets Between.. Different Instrument types? or.. Instruments of the same type? or.. On more than 1 measuring channel, of an instrument of the same type? Instrument 1, 2 & 3 Instrument 1, 2 & 3 Measure Cell 1 & 2 J.Calleja - Melb. Path. - Sept
31 4.21 QC Targets.. Between Different Instruments Types? Instrument 1, 2 & 3 J.Calleja - Melb. Path. - Sept
32 4.21 Recoveries differ for different instruments with different methodologies & calibration techniques PSA Abbott Architect You generally, Can t use the same targets, across different instrument t types! Vitros ECi Siemens Vista Roche e602 J.Calleja - Melb. Path. - Sept
33 Between.. Different Instrument types? Instrument 1, 2 & 3 Even if you have aligned the performances between analysers through Alignment Factors Recoveries for QC may still differ significantly!! - Albumin - BCP vs BCG / - if you have Bovine supplementation -> Albumin will be lower for BCP. - Creatinine - Integra vs. Cobas c701 - High Bilirubin (~ 80 umol/l) in Level-2 QC -> Lower creat. On Integra -> May need instrument specific Targets & Limits J.Calleja - Melb. Path. - Sept
34 4.22 QC Targets.. Between Same Instrument Types? Instrument 1, 2 & 3 J.Calleja - Melb. Path. - Sept
35 4.2 Parallel Analysis on Multiple Channels/ Instruments Callum Fraser states.... Quality specifications can be set.. for the allowable differences between two methods.. used to analyse the same analyte in the same laboratory; Allowable difference < 0.33 CV i J. Calleja - Melbourne Pathology 35
36 4.22 Eg. MPS Glucose Cobas c701 - Recoveries are quite consistent across 3 instruments Glucose Suggests - you can use the same targets, between instruments of the same type! Line 1 Line 1 Line 2 Line 2 Line 3 Line 3 Same: Tgt 4.75, 1sd 0.13 CV=2.7% Same: Tgt 15.4, 1sd 0.3 CV=1.9 % 0.5CVi (Gluc) =3.25 % J.Calleja - Melb. Path. - Sept
37 4.22 Eg. MPS Glucose Cobas c701 - Are the recoveries across the 3 different c701s.. < 0.33CVi? Max Bias L1: ( ) = /4.735 = 0.63% MaxBiasL2: ( ) 4) = / /15 = 0.52% Line 1 Yes! Inter-Instrument Bias is < 0.33CVi Line 2 Line 3 CV Goals, Opt, Des, Min = 1.63, 3.25, 4.9% / Bias Goal 0.33CVi = 2.15% J.Calleja - Melb. Path. - Sept
38 4.22 Eg. TSH Cobas e602 - Review of Performance for 5 Channels measuring TSH using common targets & Limits. You can use the same targets, between instruments of the same type! Chnl 1 Chnl 2 Chnl 3 Chnl 1 Chnl 2 Chnl 3 Chnl 1 Chnl 2 Chnl 3 Max Bias 2.4% Max Bias 2.17% Max Bias 2.0% Chnl 4 Chnl 5 Chnl 4 Chnl 5 Chnl 4 Chnl 5 Yes! Inter-Instrument Bias is < 0.33CVi Tgt 101sd 1.0,1sd CV=3 3.5% Tgt , 1sd 0.2 CV=3 3.33% 33% Tgt 26.7, 1sd 1.0 CV=3.7% CV Goals, Opt, Des, Min = 4.93, 9.8,14.7% / Bias Goal 0.33CVi = 6.5% J.Calleja - Melb. Path. - Sept
39 4.23 Other Advantages - of using common Targets across analysers. Common Targets & Limits mean.. Less of an Administrative Nightmare! Each Line item represents a channel on which Glucose can be measured. To capture the QC data from all the individual instruments/channels on the automation lines we have to define specific lab numbers (35 total) for each instrument/channel combination. J. Calleja - Melbourne Pathology We also must define a target & limit for each channel that an analyte can be measured on. 39
40 4.23 Further Advantage - It s Visually Easier to Keep Track of Inter- Instrument Alignment. Glucose SHBG Line 1 Line 1 Line 2 Line 2 Line 3 One channel shows a shift! Good Alignment! J.Calleja - Melb. Path. - Sept
41 4.23 However, Consider some of the Disadvantages! Common Targets & Limits it mean; The target is always a compromise b/w the mean values of all the analysers g Mean There can be a broadening of the overall variance; SD overall = (sd 2 m1 + sd 2 m2 + sd 2 m3) Can be a challenge to set an SD that sits within the Desirable Biological i l Goals & accommodates the spread of results across the analysers. Can t use Westgard s Bias Rules 10 mean or 4 x 1s rule - Otherwise these rules would be continually firing. J. Calleja - Melbourne Pathology Tn T Mod 1 Mod 2 Mod 3 Mod 1 Mod 2 Mod 3 B1-LOW B1-HI Mean B1-LOW B1-HI 41
42 4.23 Parallel Analysis on Multiple Channels/ Instruments Therefore... You need to Balance the Advantages / Disadvantages Common Targets across analysers Specific Targets on individual analysers J. Calleja - Melbourne Pathology 42
43 5.0 Setting Appropriate QC Limits? J.Calleja - Melb. Path. - Sept
44 Consider.. What guidelines or Quality Goals do we have.. to indicate... the level of quality required or.. the allowable error, we can permit.. to ensure that our results are medically useful? (eg) If we have a CV of 5% for HBA1c... is this Clinically Acceptable? J.Calleja - Melb. Path. - Sept
45 Quality Goals Hierarchy Provided by the Profession Evidence Based Studies DCCT Trial - HBA1c ( CV<2.5%) IFCC ISO AACC RCPA AACB Biological Goals - Based on CV I CVa < 0.5 CVi, CVa < 0.25 CVi, CVa < 0.75 CVi Clinician Survey Barnett.. et al Profession Defined By group of experts eg. RCPA-QAP Allowable Limits Proficiency Testing Schemes State of the Art Method.or. +/- 2sd of all results submitted Publication by a Lab or Group ISO Technical Committee 212 Task Force, 1999 J.Calleja - Melb. Path. - Sept
46 We can illustrate the importance of Analytical CV on result interpretation!.. Using inferences from the 1993 DCCT Trial.. J.Calleja - Melb. Path. - Sept
47 Remember... When we analyse a patient sample, there are 2 components of variation: Analytical l CV A & Biological CV i This is represented as CV T = (CV A 2 + CV i2 ) 1/2 J.Calleja - Melb. Path. - Sept
48 5.6 Effect of CV A on Result Interpretation CV T = (CV A2 + CV i2 ) 1/2 8.5 CV T = ( ) 1/ CV T = 3.6 % 9 HBA1c - Effect of CV on result interpretation -CVa=0 % Depiction of pure Biological Signal Only! low risk 7.5 High Risk In the DCCT Trial Intensive Treatment Cohorts had Mean HBA1cs of 7% Conventional Treatment Cohorts had Mean HBA1cs of 9%.. CVi (HBA1c) = 3.6%... We can use this study to illustrate the variation due to CVi alone, at these levels J.Calleja - Melb. Path. - Sept
49 Effect of CV A on Result Interpretation CV T = (CV A2 + CV i2 ) 1/2 HBA1c - Effect of CV A on result interpretation - CV A =2.5 % 11 Adequate Cva to distinguish 10.5 CV = /2 Low & High Risk cohorts. T ( ) 10 - Evidence Based Goal CV T = 4.38% At the Evidence Based HBA1c CV A Goal; CV A = 2.5% There is adequate distinction between cohorts! Low Risk High Risk J.Calleja - Melb. Path. - Sept
50 .. So.. minimising our analytical variation.. clearly l assists in patient result interpretation!.. But how much is enough?.. Given to us by Callum Fraser J.Calleja - Melb. Path. - Sept
51 5.7 Effects of Imprecision on Test Result Variability % increase in variability CVi adds 3% variability CVi adds 25% variability. Desirable Goal CVi adds 12% variability. Biological CV Goal. Ref. Biological Variation Principles to Practice Callum Fraser J.Calleja - Melb. Path. - Sept
52 6.0 What steps should we follow when we set our QC Limits. J.Calleja - Melb. Path. - April
53 6.1 Setting Appropriate p QC Ranges - Steps Involved.. Consider Quality Goals & Method Capability Don t just blindly use Mean +/- 2sd! Step 1 - Review the SDs & CVs achieved from The Target Setting Studies - Compare this to the Labs Ongoing CVs at similar concentrations Step 2 - Compare the labs achieved CV performance to the Instrument Manufacturer s.. stated CV specifications for Total CV - Refer to the manufacturers kit insert Step 3 - Consider the Relevant Quality Goals ( CV Desired), from the ISO TC212 Hierarchy ; Evidence Based / Biol. Var n / QAP Allowable Limits Step 4 - Consider the State-of-The-Art Performances - Compare CVs to QAP 20 th, 50 th & method Median CVs (E.O.C.Rs) Step 5 - Put all of this information together to determine what the allowable CV ( or Quality Goal ).. for your assay, should be. J.Calleja - Melb. Path. - Sept
54 6.2.1 Setting QC Ranges - Acceptable Limits Lab about to set targets & sd s for 2 qc s for Trigs on a Beckman analyser.. Based on achieved Evaluation Study performances QC Level-1 QC Level-2 Tgt = 1.00 Tgt = 2.2 Are these ranges appropriate? SD = CV = 5.1% SD = 0.1 CV = 4.5% Range: Range: Min = 0.9 Min = 2.0 Max = 1.1 Max = 2.4 J.Calleja - Melb. Path. - Sept
55 ? Appropriate QC Limits Lab Ongoing CVs J.Calleja - Melb. Path. - Sept
56 Labs Ongoing CVs Lab s Ongoing CVs Tgt = 0.95 Tgt = 2.0 SD = SD = 0.07 CV = 3.8% CV = 3.5% Lab s Evaln. CVs Tgt = 1.00 SD = Tgt = 2.2 SD = 0.1 CV = 5.1% The Lab s Eval. CVs Range: CV = 4.5% Range: are higher than routine CVs Min = 0.9 Min = 2.0 Max = 1.1 Max = 2.4 J.Calleja - Melb. Path. - Sept
57 ? Appropriate QC Limits Manufacturer Specifications J.Calleja - Melb. Path. - Sept
58 Trig - Expected Performance Note: Expected level Tgt = 1.00 SD = CV = 5.1% Range: Min = 0.9 Max = 1.1 Tgt = 2.2 SD = 0.1 CV = 4.5% Range: Min = 2.0 Max = 2.4 The Lab s QC CVs are J.Calleja - Melb. Path. - Sept
59 ? Appropriate QC Limits Biologically Based CVa Quality Goals J.Calleja - Melb. Path. - Sept
60 ? Appropriate QC Limits Refer to Westgard Web-site ( CVi = 20.9% J.Calleja - Melb. Path. - Sept
61 Labs Trig QC Goals vs. Biological Limits Biological i l Variability CV i (Triglyceride) = 20.9 % Lab s achieved CVs are Within Desirable & Optimal Biological Goals 1. Calculate the Analytical CV Goals Tgt = 1.00 Tgt = 2.2 CV a Optimal = 0.25 CV i = 5.25% CV a Desirable = 0.5 CV i = 10.5% CV a Minimal = 0.75 CV i = 15.75% SD = 0.51 CV = 5.1% Range: Min = 0.9 SD = 0.1 CV = 4.5% Range: Min = 2.0 Max = 1.1 Max = Compare Lab s CVs w Biological Goals J.Calleja - Melb. Path. - Sept
62 ? Appropriate QC Limits QAP Allowable Limits J.Calleja - Melb. Path. - Sept
63 Labs Trig QC Goals.vs. QAP Limits Labs Eval CVs Tgt = 1.00 Tgt = 2.2 SD = SD = 0.1 CV = 5.1% CV = 4.5% Range: Range: Min = 0.9 Min = 2.0 Max = 1.1 Max = 2.4? How do the Lab s CV goals Compare with QAP Allowable Limits J.Calleja - Melb. Path. - Sept
64 Labs Trig QC Goals.vs. QAP Limits What CV do we need to achieve 95.5% 5% of all results.. within the QAP Allowable Limits..? We can consider the QAP Target & Allowable Limits i as.. mean +/- 2 sd (95% C.I.) So.. 1sd = ( ) / 2 = 0.1 So.. CV required is.. ( 0.1 / 1.71 ) x 100 = 5.8 % J.Calleja - Melb. Path. - Sept
65 Labs Trig QC Goals.vs. QAP Limits What CV do we need to achieve 99.7% of all results.. within the QAP Allowable Limits.. Can consider Allowable range as mean +/- 3 sd (99.7% C.I.) So.. 1sd = ( ) / 3 = So.. CV required is.. ( 0.1 / 1.71 ) x 100 = 3.9 % J.Calleja - Melb. Path. - Sept
66 Labs Trig QC Goals.vs. QAP Limits Labs Eval. CVs are within the QAP Allowable Limits Labs Eval. CVs Tgt = 1.00 Tgt = 2.2 SD = SD = 0.1 CV = 5.1% CV = 4.5% Range: Range: Min = 0.88 Min = 2.0 Max = 1.12 Max = 2.4 Calculate CV goals for the Lab based on their mean values & QAP 2.2, 1SD=0.11 1SD=0.1 CV= 10% J.Calleja - Melb. Path. - Sept
67 ? Appropriate QC Limits State of the Art Performances J.Calleja - Melb. Path. - Sept
68 ? Appropriate QC Limits State-of-the-Art the 50 th percentile CV = 3.2% 20 th percentile CV = 2.4% Method Median CV = 3.5% J.Calleja - Melb. Path. - Sept
69 Put it All Together! Manufacturers CV Specs. Biological Goals CV a Optimal = 0.25 CV i = 5.25% CV a Desirable = 0.5 CV i = 10.5% CV a Minimal RCPA QAP ALEs = 0.75 CV i = 15.75% Lab s Evaluation CVs Tgt = Tgt = SD = SD = 0.1 CV = 5.1% CV = 4.5% Lab s Ongoing CVs Tgt = 0.95 Tgt = 2.0 SD = SD = CV = 3.8% CV = 3.5% ½ QAP ALE CV = 5.8% 1/3 QAP ALE Set Targets to: Lev 1: Tgt =1.0 1SD=0.037, CV= 3.7% Lev 2: Tgt=2.2, 1SD=0.075 CV=3.5% QAP State-of-the-Art CV = 3.9% 50 th %CV = 3.2% 20 th %CV = 2.4% Method CV = 3.5% J.Calleja - Melb. Path. - Sept
70 Also Consider Process Capability.. J.Calleja - Melb. Path. - Sept
71 Process Capability.. Cp Cp - is an index which relates the Allowable process spread.. to the.. Actual process spread Allowable Process Spread USL - LSL Cp = = Actual Process Spread 6sd Cp = 2 LSL Cp = 1 USL J.Calleja - Melb. Path. - Sept
72 Process Capability.. Cp - A High Cp Index is desirable... ie. A systematic shift can occur.. but.. your results will still be within the Allowable Limits. Consider : a) Cp = 2.. desirable b) Cp = 1.. Less desirable.. LSL USL LSL USL J.Calleja - Melb. Path. - Sept
73 Process Capability.. Cp - If you have a Method with excellent precision i... (eg) Better than Optimal Biological Variation Goals.. - Method can shift.. but results remain within the allowable Limits.. LSL USL Set allowable SD.. to match the Desirable Biol Goal J.Calleja - Melb. Path. - Sept
74 A Spread-Sheet Sheet Can Help Manage the Goals Lab QC Settings. Manufacturers CV Specs. J.Calleja - Melb. Path. - Sept
75 A Spread-Sheet Can Help Manage the Goals CV you need for SD = ½ ALE (95%) or SD = 1/3 ALE (99%) QAP Allowable Limits J.Calleja - Melb. Path. - Sept
76 A Spread-Sheet Can Help Manage the Goals CVI & CVG Opt, Des, Opt Biol Cva Goals Opt, Des, Opt Bias Goals J.Calleja - Melb. Path. - Sept
77 A Spread-Sheet Can Help Manage the Goals Your test Capabilities Which Biol. CV Goal achieving Whether achieving ½ QAP ALE (95%) or 1/3 QAP ALE (99%) Method Capability Whether achieving Manufacturer B/R CV J.Calleja - Melb. Path. - Sept
78 7.0 What do we do if we have ashift? Will not be discussed in the interests of time! J.Calleja - Melb. Path. - Sept
79 What level l of Bias is acceptable? Can be explained in the context of Ref. Intervals J.Calleja - Melb. Path. - Sept
80 7.1 What level of Bias is Acceptable? Callum Fraser.. discusses that the Reference Interval is made up of; With-in Subject & CV i Between Subject Variation CV G For all of us to use the same Reference Interval,.. the analytical Bias should be less than ¼ of the grouped Biological Variation. This is represented as: B < 0.25 (CV 2 A G + CV i2 ) 1/2 Becomes a Default Bias Goal! J.Calleja - Melb. Path. - Sept
81 Impact of a Shift or Bias Shift in Assay causing +ve Bias Results in <2.5% out of LRL Results in False Positives, > 2.5% out of U.R.L. +/-2sd = 95.5% Reference Interval! (c) John Calleja Melb Path 81
82 7.2 How much of the Population o is Displaced by Bias? % Out of each Ref Limit % of Results Outside of URL When Bias = 0 2.5% either side of Ref Limits % of Results Outside of LRL Desirable Bias B A < (CV I 2 + CV G2 ) 1/2 adds 2% outside of Ref Interval. B A < (CV I 2 + CV G2 ) 1/2 adds 16% B A < (CV I 2 + CV G2 ) 1/2 adds 34% Bias Goal. Ref. Biological Variation Principles to Practice Callum Fraser J.Calleja - Melb. Path. - Sept
83 Alternatively ti l We could use; Callum Fraser s.. Quality specifications.. for the allowable differences between two methods.. used to analyse a the same analyte a in the same laboratory; Allowable difference < 0.33 CV i J. Calleja - Melbourne Pathology 83
84 How should we Assess / Action a shift? J.Calleja - Melb. Path. - Sept
85 Assessing / Actioning a Shift Possible Actions: Assess Magnitude of Shift Percent deviation from QC Target or %Bias Pre & Post shift patient comparison studies Patient Data Extract movement in averages & percentiles Attribute a Cause Eg. Reagent or Cal Lot Change Reagent Reformulation Assess Clinical Relevance Clinical Consultation, 0.25 x (CV I2 +CV G2 ) 1/2, 0.33CVi Consultation with Manufacturer about a corrective action. New Lot Number of Calibrator / Rgt Calibrator Set Point Reassignment Apply a corrective Slope &/or Offset to results Derived from Pre & Post shift.. patient comparison studies Examination of influence of shift on patient averages Take Corrective Action Change QC Targets / Pt. Ref. Intervals, to compensate for the shift (c) John Calleja Melb Path 85
86 Attribute the Cause? eg. CEA Start w LJ Plots Draw in dates of reagent & calibrator lot changes etc.. Attribute the Cause, of the shift -> -> Shift due to Reagent Lot Change (Lot ) Estimate Bias Magnitude: Target Shift to Diff % Diff % J.Calleja - Melb. Path. - Sept
87 Estimate Magnitude of Shift eg. Pt. Comparisons for Ca++ Bias.. Post vs. Pre New Lot of Calibrator Y = x At URL: 2.6 mmol/l New Result = Bias = %Bias = 3.02% Assess against: 0.33CVi (1.9) = 0.63% -> 3.02% Worse Assess against: (CV 2 I + CV G2 ) 1/2 = 0.85% ->3.02% Worse (CV 2 I + CV G2 ) 1/2 = 1.27% -> 3.02% Worse (c) John Calleja Melb Path 87
88 What if we initially missed the shift.. &.. can t perform patient sample comparisons? J.Calleja - Melb. Path. - Sept
89 Perform Patient Data Extracts - Plot Patient Medians/Percentiles How Extract Data from LIS for a period including before & after the shift Calculate moving medians.. per 30.. or.. per 1000 sample results (if lots of data) Plot.. Moving Median vs. Date/Time Examine for a significant shifts / Estimate Magnitude Most useful.. when the detection of a shift has initially been missed. (c) John Calleja Melb Path 89
90 Patient Data Extracts - example: raw data Write Formulas to calculate the median for the preceding 30 samples =Median(F2:F31) =Median (F3:F32) =Median(F4:F33) Copy Formulas down spreadsheet.. to get rest of.. rolling 30 sample medians. (c) John Calleja Melb Path 90
91 - Example: Plot the Moving Median versus Date/Time Moving Median Sensitive to the Shift Bias ~ 0.15 mmol/l (c) John Calleja Melb Path 91
92 What if we decide we have a Clinically i ll Significant ifi Shift.. J.Calleja - Melb. Path. - Sept
93 Could Derive a Corrective Slope & Offset to realign the performances Y = x Re-Performed Comparisons with Slope & Offset installed Derived Corrective Slope & Offset (from Regression Eq): Slope = (1/1.0965) = 0.91 Offset = (0.1723/1.0965) = Method Alignment Improved (c) John Calleja Melb Path 93
94 What do we do with QC Targets?... J.Calleja - Melb. Path. - Sept
95 What do we do about QC Targets? If Shift assessed as Clinically Tolerable Calculate the mean values for all relevant QC levels including data after the Shift! Re-Assign the QC Target Values to these values If Shift assessed as Clinically i ll Significant ifi If Corrective Factors Implemented Should be no need to amend QC Targets Exceptions Where QC matrix behaves different to Patients If Reference Intervals modified.. (eg. due to assay Re-Standardisation) Calculate the mean values for all relevant QC levels including data after the Shift! Re-Assign the QC Target Values to these values (c) John Calleja Melb Path 95
96 What do we do about QC Limits? If you have already carefully calculated CV Goals.. -> Re-calculate your SDs.. to achieve equivalent CV goals, at the new target concentration. CV % = (SD/Mean ) x 100 If Former (Pre-Shift) Target = 100, SD = 5, CV Goal = 5% If Assay Shifted to Mean= 80 To maintain a CV Goal of 5% Re-arrange CV equation to solve for SD SD = (CV/100) x Mean SD = (5/100) x 80 SD = 4 (c) John Calleja Melb Path 96
97 8. Summary Kit Insert Target Values.. &.. Consensus Values from QC DBs are a reliable place to start. Kit Insert QC limits need closer scrutiny. Ideally we should establish our own targets & limits. We need Data points to ascribe a confident Target. You generally cannot use a common target across different instrument types You can use a common target between instruments/channels of the same type Consider Quality Goals hierarchy & method capability, when setting QC Limits If you have a persistent shift The magnitude should be assessed against Biologically Based Goals If insignificant, QC Targets & Limits should be revised, If significant - Corrective action should be taken. J.Calleja - Melb. Path. - Sept
98 References J.Calleja - Melb. Path. - Sept
IQC monitoring in laboratory networks
IQC for Networked Analysers Background and instructions for use IQC monitoring in laboratory networks Modern Laboratories continue to produce large quantities of internal quality control data (IQC) despite
More informationReference Guide for the Value Assignment Web v
Reference Guide for the Value Assignment Web v 1.02.01 Bio-Rad Laboratories 9500 Jeronimo Road Irvine, CA 92618 Copyright 2008 Contents Introduction to the Value Assignment Web 1 Benefits of the Value
More informationDevelopments in harmonised scoring systems and data presentation 'The ABC of EQA
UK NEQAS UK NEQAS FOR CLINICAL CHEMISTRY UNITED KINGDOM NATIONAL EXTERNAL QUALITY ASSESSMENT SCHEMES Developments in harmonised scoring systems and data presentation 'The ABC of EQA Dr David G Bullock
More informationThe NGAL Test Application Note for Abbott Architect c8000
The NGAL Test Application Note for Abbott Architect c8 General parameters Name: NGAL Assay number: *1 Assay version: 1 Assay type: Photometric Assay availability: Enabled Cal version: 1 Reaction definition
More informationHelp Manual Version R07
Help Manual Version 2.8.0.R07 January 2016 1 Contents: 1 Introduction... 5 1.1 PC Configuration... 5 1.1.1 Internet Explorer 6 configuration to generate the rules file.... 6 1.1.2 Internet Explorer 7 configuration
More informationTIQCon TM. Lab chain manager User manual. Software version Author : Siegmar Zaske
TIQCon TM Lab chain manager User manual Software version 1.1.0 Author : Siegmar Zaske Zaske Software & Technik GmbH Frankfurter Straße 46a D-65520 Bad Camberg TIQCon TM lab chain manager page 1 from 8
More informationLearner Expectations UNIT 1: GRAPICAL AND NUMERIC REPRESENTATIONS OF DATA. Sept. Fathom Lab: Distributions and Best Methods of Display
CURRICULUM MAP TEMPLATE Priority Standards = Approximately 70% Supporting Standards = Approximately 20% Additional Standards = Approximately 10% HONORS PROBABILITY AND STATISTICS Essential Questions &
More informationDRI ETHYL ALCOHOL ASSAY APPLICATION Beckman Coulter AU400, AU480, AU640, AU680, AU2700, AU5400, AU5800
DRI ETHYL ALCOHOL ASSAY APPLICATION Beckman Coulter AU400, AU480, AU640, AU680, AU2700, AU5400, AU5800 Catalog No. 0037, 0038 Intended for the quantitative determination of alcohol in human urine, serum
More informationLBMA Proficiency Testing
LBMA Proficiency Testing Jonathan J. Jodry Metalor Technologies SA, Switzerland LBMA Assaying and Refining Conference 20-21 March 2017, London Topics What is a Proficiency Testing? Sample composition,
More informationQMS AMIKACIN ASSAY APPLICATION Beckman Coulter AU400, AU480, AU640, AU680, AU2700, AU5400, AU5800
Microgenics Corporation Part of Thermo Fisher Scientific QMS AMIKACIN ASSAY APPLICATION Beckman Coulter AU400, AU480, AU640, AU680, AU2700, AU5400, AU5800 Catalog No. 0373910 & 10017196 Intended for the
More informationELECTIVES MODULES. Implement. Electives. Setup. Troubleshooting. Basics
ELECTIVES MODULES Implement Electives Setup Troubleshooting Basics This document is not intended to replace the information in your Instrument Instructions for Use Manual (IFU). Information in the Instructions
More informationBIOL 417: Biostatistics Laboratory #3 Tuesday, February 8, 2011 (snow day February 1) INTRODUCTION TO MYSTAT
BIOL 417: Biostatistics Laboratory #3 Tuesday, February 8, 2011 (snow day February 1) INTRODUCTION TO MYSTAT Go to the course Blackboard site and download Laboratory 3 MYSTAT Intro.xls open this file in
More informationEP Evaluator meets Instrument Manager
EP Evaluator meets Instrument Manager Using ODBC to capture your data Carol R Lee Data Innovations, Implementation Consultant datainnovations.com Copyright Data Innovations, LLC 2014 1 EP Evaluator meets
More informationTaKe COmmanD OF. YOur gamma. COunTing. WIZARD 2 Automated Gamma Counters
TaKe COmmanD OF YOur gamma COunTing WIZARD 2 Automated Gamma Counters The One to Count On For Years to Come Whether you re conducting research, testing or monitoring, you know that gamma counting delivers
More informationError Analysis, Statistics and Graphing
Error Analysis, Statistics and Graphing This semester, most of labs we require us to calculate a numerical answer based on the data we obtain. A hard question to answer in most cases is how good is your
More informationMHPE 494: Data Analysis. Welcome! The Analytic Process
MHPE 494: Data Analysis Alan Schwartz, PhD Department of Medical Education Memoona Hasnain,, MD, PhD, MHPE Department of Family Medicine College of Medicine University of Illinois at Chicago Welcome! Your
More informationDiploma of Laboratory Technology. Assessment 2 Control charts. Data Analysis. MSL Analyse data and report results.
Diploma of Laboratory Technology Assessment 2 Control charts Data Analysis MSL925001 Analyse data and report results www.cffet.net PURPOSE 2 ASSESSMENT MAP 2 SUBMISSION 2 GETTING STARTED 3 TASK 1 X CHART
More informationACCREDITATION COMMISSION FOR CONFORMITY ASSESSMENT BODIES
ACCREDITATION COMMISSION FOR CONFORMITY ASSESSMENT BODIES ACCREDITATION SCHEME MANUAL Document Title: Document Number: Various Accreditation Schemes ACCAB-ASM-7.0 CONTROLLED COPY Revision Number Revision
More informationRIQAS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME ENROLMENT DOCUMENT GENERAL CLINICAL CHEMISTRY PROGRAMME RQ9112/9113
RIQAS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME ENROLMENT DOCUMENT GENERAL CLINICAL CHEMISTRY PROGRAMME RQ9112/9113 This document must be completed and returned to RIQAS RIQAS GENERAL CLINICAL CHEMISTRY
More informationPart One of this article (1) introduced the concept
Establishing Acceptance Limits for Uniformity of Dosage Units: Part Two Pramote Cholayudth The concept of sampling distribution of acceptance value (AV) was introduced in Part One of this article series.
More informationCEDIA METHADONE APPLICATION Beckman Coulter AU480 & AU680
Microgenics Corporation Part of Thermo Fisher Scientific CEDIA METHADONE APPLICATION Beckman Coulter AU480 & AU680 Catalog No. 100088, 100097, 1730916 Intended for the Qualitative and Semiquantitative
More informationSTA Module 2B Organizing Data and Comparing Distributions (Part II)
STA 2023 Module 2B Organizing Data and Comparing Distributions (Part II) Learning Objectives Upon completing this module, you should be able to 1 Explain the purpose of a measure of center 2 Obtain and
More informationSTA Learning Objectives. Learning Objectives (cont.) Module 2B Organizing Data and Comparing Distributions (Part II)
STA 2023 Module 2B Organizing Data and Comparing Distributions (Part II) Learning Objectives Upon completing this module, you should be able to 1 Explain the purpose of a measure of center 2 Obtain and
More informationCEDIA BARBITURATES APPLICATION Beckman Coulter AU480, AU680
CEDIA BARBITURATES APPLICATION Beckman Coulter AU480, AU680 Catalog No. 100084, 100093, 1661213, 10017365 Microgenics Corporation Part of Thermo Fisher Scientific Intended for the Qualitative and Semiquantitative
More informationRegulatory Aspects of Digital Healthcare Solutions
Regulatory Aspects of Digital Healthcare Solutions TÜV SÜD Product Service GmbH Dr. Markus Siebert Rev. 02 / 2017 02.05.2017 TÜV SÜD Product Service GmbH Slide 1 Contents Digital solutions as Medical Device
More informationSTA Rev. F Learning Objectives. Learning Objectives (Cont.) Module 3 Descriptive Measures
STA 2023 Module 3 Descriptive Measures Learning Objectives Upon completing this module, you should be able to: 1. Explain the purpose of a measure of center. 2. Obtain and interpret the mean, median, and
More informationCpk: What is its Capability? By: Rick Haynes, Master Black Belt Smarter Solutions, Inc.
C: What is its Capability? By: Rick Haynes, Master Black Belt Smarter Solutions, Inc. C is one of many capability metrics that are available. When capability metrics are used, organizations typically provide
More informationConfidence Intervals. Dennis Sun Data 301
Dennis Sun Data 301 Statistical Inference probability Population / Box Sample / Data statistics The goal of statistics is to infer the unknown population from the sample. We ve already seen one mode of
More informationParallel line analysis and relative potency in SoftMax Pro 7 Software
APPLICATION NOTE Parallel line analysis and relative potency in SoftMax Pro 7 Software Introduction Biological assays are frequently analyzed with the help of parallel line analysis (PLA). PLA is commonly
More informationAverages and Variation
Averages and Variation 3 Copyright Cengage Learning. All rights reserved. 3.1-1 Section 3.1 Measures of Central Tendency: Mode, Median, and Mean Copyright Cengage Learning. All rights reserved. 3.1-2 Focus
More informationRIQAS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME METHOD QUESTIONNAIRE CYFRA 21-1 PROGRAMME (CYTOKERATIN 19) RQ9175
RIQAS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME METHOD QUESTIONNAIRE CYFRA 21-1 PROGRAMME (CYTOKERATIN 19) RQ9175 Please be aware that the RIQAS Instrument and reagent supplier codes are now in a
More informationmyvirena.com Training Guide
myvirena.com Training Guide Registering as a New User... 3 User Roles... 5 Healthcare Provider Roles... 5 Organizational Administrator... 5 Authorized User... 5 Public Health Roles... 5 Country... 5 State...
More informationVITROS TDM Performance Verifier is prepared from bovine serum to which therapeutic drugs, inorganic salts, and preservatives have been added.
VITROS Chemistry Products TDM Performance Verifier I, II, and III TDM Performance Verifier I, II, and III 896 2540 179 2357 818 2172 Rx ONLY Intended Use For in vitro diagnostic use only. VITROS Chemistry
More informationGraphical Analysis of Data using Microsoft Excel [2016 Version]
Graphical Analysis of Data using Microsoft Excel [2016 Version] Introduction In several upcoming labs, a primary goal will be to determine the mathematical relationship between two variable physical parameters.
More informationDescriptive Statistics, Standard Deviation and Standard Error
AP Biology Calculations: Descriptive Statistics, Standard Deviation and Standard Error SBI4UP The Scientific Method & Experimental Design Scientific method is used to explore observations and answer questions.
More informationAnd the benefits are immediate minimal changes to the interface allow you and your teams to access these
Find Out What s New >> With nearly 50 enhancements that increase functionality and ease-of-use, Minitab 15 has something for everyone. And the benefits are immediate minimal changes to the interface allow
More informationChapter 2 Modeling Distributions of Data
Chapter 2 Modeling Distributions of Data Section 2.1 Describing Location in a Distribution Describing Location in a Distribution Learning Objectives After this section, you should be able to: FIND and
More informationKaluza C Analysis Software PROTECTS YOUR DATA AND YOUR REPUTATION.
Kaluza C Analysis Software PROTECTS YOUR DATA AND YOUR REPUTATION. KALUZA C ANALYSIS SOFTWARE Kaluza C Flow Cytometry Analysis Software is built upon our successful Kaluza Analysis research use platform.
More informationmyvirena.com User Manual / Training Guide
myvirena.com User Manual / Training Guide Registering as a New User... 3 User Roles... 5 Healthcare Provider Roles... 5 Organizational Administrator... 5 Authorized User... 5 Public Health Roles... 5 Country...
More informationTips and Guidance for Analyzing Data. Executive Summary
Tips and Guidance for Analyzing Data Executive Summary This document has information and suggestions about three things: 1) how to quickly do a preliminary analysis of time-series data; 2) key things to
More informationQQ normality plots Harvey Motulsky, GraphPad Software Inc. July 2013
QQ normality plots Harvey Motulsky, GraphPad Software Inc. July 213 Introduction Many statistical tests assume that data (or residuals) are sampled from a Gaussian distribution. Normality tests are often
More informationWhat is Process Capability?
6. Process or Product Monitoring and Control 6.1. Introduction 6.1.6. What is Process Capability? Process capability compares the output of an in-control process to the specification limits by using capability
More informationAn Overview of Proficiency Testing in Sensory Analysis Chantal Gilbert
An Overview of Proficiency Testing in Sensory Analysis Chantal Gilbert Slide 1 Outline What is proficiency testing? Adapting proficiency testing to Sensory Measurement criteria for panel proficiency Ranking
More informationThis document serves as a guide only and does not supersede clinical judgment.
CCAT istat Use Clinical Practice Guideline Original Release Date: Mar 2013 Most Recent Review/Revision: 19 Mar 2013 Authors and Peer Reviewers: Capt John-Michael Fowler, Peer Reviewers: SSgt Tyler Britton,
More informationDRI CREATININE-DETECT APPLICATION BECKMAN COULTER AU640, AU680
Microgenics Corporation Part of Thermo Fisher Scientific DRI CREATININE-DETECT APPLICATION BECKMAN COULTER AU640, AU680 Catalog No. 1797 Intended for the quantitative determination of creatinine in human
More informationVaccine data collection tool Oct Functions, Indicators & Sub-Indicators
data collection tool Oct. 2011 A. National Regulatory System RS01: Legal framework for establishment of a regulatory system, mandate and enforcement power for each function RS01.01: Legislation or and
More informationImpact of 3D Laser Data Resolution and Accuracy on Pipeline Dents Strain Analysis
More Info at Open Access Database www.ndt.net/?id=15137 Impact of 3D Laser Data Resolution and Accuracy on Pipeline Dents Strain Analysis Jean-Simon Fraser, Pierre-Hugues Allard Creaform, 5825 rue St-Georges,
More informationACCREDITATION COMMISSION FOR CONFORMITY ASSESSMENT BODIES
ACCREDITATION COMMISSION FOR CONFORMITY ASSESSMENT BODIES ACCREDITATION SCHEME MANUAL Document Title: Document Number: Various Accreditation Schemes ACCAB-ASM-7.0 CONTROLLED COPY Revision Number Revision
More informationISO/IEC Accreditation: The Big Picture and Getting Started
ISO/IEC 17025 Accreditation: The Big Picture and Getting Started John Szpylka, Ph.D. Scientific Affaires Director, Chemistry N.A. AAFCO 2017 Midyear Meeting Takeaways Accreditation versus Certification
More informationNHS Health Check Internal/External Quality control Crib Sheet. Table of Contents. Alere Afinion HbA1c Control (Internal)
NHS Health Check Internal/External Quality control Crib Sheet Table of Contents Alere Afinion HbA1c Control (Internal) Page 2 WEQAS HbA1c Quality Control Assessment (External) Page 3 WEQAS Afinion Lipid
More information3 Graphical Displays of Data
3 Graphical Displays of Data Reading: SW Chapter 2, Sections 1-6 Summarizing and Displaying Qualitative Data The data below are from a study of thyroid cancer, using NMTR data. The investigators looked
More informationWELCOME! Lecture 3 Thommy Perlinger
Quantitative Methods II WELCOME! Lecture 3 Thommy Perlinger Program Lecture 3 Cleaning and transforming data Graphical examination of the data Missing Values Graphical examination of the data It is important
More informationSTA 570 Spring Lecture 5 Tuesday, Feb 1
STA 570 Spring 2011 Lecture 5 Tuesday, Feb 1 Descriptive Statistics Summarizing Univariate Data o Standard Deviation, Empirical Rule, IQR o Boxplots Summarizing Bivariate Data o Contingency Tables o Row
More informationUsing Excel for Graphical Analysis of Data
EXERCISE Using Excel for Graphical Analysis of Data Introduction In several upcoming experiments, a primary goal will be to determine the mathematical relationship between two variable physical parameters.
More informationTRACEABILITY and UNCERTAINTY 7
cobas c 01 / c 02 / c 11 / c 701 / c 702 - C.f.a.s. Cat. No. 10 79 0 190 ACP2 Acid phosphatase total 1-naphthyl phosphate Gen. 2 ACP2 Acid phosphatase, non-prostatic 1-naphthyl phosphate (Inhib.:tartrate)
More informationNATIONAL BOARD OF MEDICAL EXAMINERS Subject Examination Program. Introduction to Clinical Diagnosis Examination Paper Version
NATIONAL BOARD OF MEDICAL EXAMINERS Examination Paper Version Score Interpretation Guide NBME subject examinations provide medical schools with a tool for measuring examinees' understanding of the basic
More informationCHAPTER 3 AN OVERVIEW OF DESIGN OF EXPERIMENTS AND RESPONSE SURFACE METHODOLOGY
23 CHAPTER 3 AN OVERVIEW OF DESIGN OF EXPERIMENTS AND RESPONSE SURFACE METHODOLOGY 3.1 DESIGN OF EXPERIMENTS Design of experiments is a systematic approach for investigation of a system or process. A series
More informationDRI ph-detect APPLICATION BECKMAN COULTER AU640, AU680
Microgenics Corporation Part of Thermo Fisher Scientific DRI ph-detect APPLICATION BECKMAN COULTER AU640, AU680 Catalog No. 100054 Intended for the determination of urine ph. For In Vitro Diagnostic Use
More informationCOBAS INTEGRA 400 plus
COBAS INTEGRA 400 plus COBAS INTEGRA 400 plus is designed to consolidate testing and increase efficiency while reducing total running costs of the laboratory. The COBAS INTEGRA systems extensive assay
More informationDRI OXYCODONE APPLICATION BECKMAN COULTER AU480, AU680, AU5800
Microgenics Corporation Part of Thermo Fisher Scientific DRI OXYCODONE APPLICATION BECKMAN COULTER AU480, AU680, AU5800 Catalog No. 100248, 100249, 10015632 The DRI Oxycodone Enzyme Immunoassay is intended
More informationUsing Excel for Graphical Analysis of Data
Using Excel for Graphical Analysis of Data Introduction In several upcoming labs, a primary goal will be to determine the mathematical relationship between two variable physical parameters. Graphs are
More informationThemes in the Texas CCRS - Mathematics
1. Compare real numbers. a. Classify numbers as natural, whole, integers, rational, irrational, real, imaginary, &/or complex. b. Use and apply the relative magnitude of real numbers by using inequality
More informationThe NGAL Test Application Note for Roche Modular P
The NGAL Test Application Note for Roche Modular P NGAL Code (ACN) xxx ANALYZE Ser/Pl type Assay/Time/Point 2-Point-End 1 18 34 Wave (2nd/Primary) 8 57 Volume Reagent Vol. Diluent BCN OBS Timing Normal
More informationData Analysis Guidelines
Data Analysis Guidelines DESCRIPTIVE STATISTICS Standard Deviation Standard deviation is a calculated value that describes the variation (or spread) of values in a data set. It is calculated using a formula
More informationDRI METHADONE METABOLITE ASSAY APPLICATION BECKMAN COULTER AU400, AU480, AU640, AU680, AU2700, AU5400, AU5800
Microgenics Corporation Part of Thermo Fisher Scientific DRI METHADONE METABOLITE ASSAY APPLICATION BECKMAN COULTER AU400, AU480, AU640, AU680, AU2700, AU5400, AU5800 Catalog Nos. 100115 and 100116 Intended
More informationAcquisition Description Exploration Examination Understanding what data is collected. Characterizing properties of data.
Summary Statistics Acquisition Description Exploration Examination what data is collected Characterizing properties of data. Exploring the data distribution(s). Identifying data quality problems. Selecting
More informationStandard INT Dynamic Transfers
Standard INT-004-3.1 Dynamic Transfers A. Introduction 1. Title: Dynamic Transfers 2. Number: INT-004-3.1 3. Purpose: To ensure Dynamic Schedules and Pseudo-Ties are communicated and accounted for appropriately
More informationMeasures of Position
Measures of Position In this section, we will learn to use fractiles. Fractiles are numbers that partition, or divide, an ordered data set into equal parts (each part has the same number of data entries).
More informationAccreditation Bodies in other
Accreditation Bodies in other WHO Regions Jeanette Twell 6July2011 Overview ILAC Accreditation International Standards vs Guidance Auditing (NATA) EQAS/Proficiency Testing Take home message 2 International
More informationFusion AE LC Method Validation Module. S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA USA Phone: URL:
Fusion AE LC Method Validation Module S-Matrix Corporation 1594 Myrtle Avenue Eureka, CA 95501 USA Phone: 707-441-0404 URL: www.smatrix.com Regulatory Statements and Expectations ICH Q2A The objective
More informationMaximizing Statistical Interactions Part II: Database Issues Provided by: The Biostatistics Collaboration Center (BCC) at Northwestern University
Maximizing Statistical Interactions Part II: Database Issues Provided by: The Biostatistics Collaboration Center (BCC) at Northwestern University While your data tables or spreadsheets may look good to
More informationBC Auto Hematology Analyzer. Pleasant Experience in Hematology Testing
BC-3600 Auto Hematology Analyzer Pleasant Experience in Hematology Testing BC-3600 Auto Hematology Analyzer Labs today are facing a multitude of challenges including limited laboratory budgets, increasing
More informationTest requesting in EMIS LV using Sunquest ICE
GP ICE User Guide 1 Placing a request... 3 1.1 Navigating around the test request screen...4 1.1.1 Panels and pages... 4 1.1.2 Selecting a test... 4 1.1.3 Excluded tests... 4 1.1.4 Included tests... 5
More information2014 Stat-Ease, Inc. All Rights Reserved.
What s New in Design-Expert version 9 Factorial split plots (Two-Level, Multilevel, Optimal) Definitive Screening and Single Factor designs Journal Feature Design layout Graph Columns Design Evaluation
More informationUniversity at Buffalo's NEES Equipment Site. Data Management. Jason P. Hanley IT Services Manager
University at Buffalo's NEES Equipment Site Data Management Jason P. Hanley IT Services Manager Structural Engineering and Earthquake Simulation Laboratory, Department of Civil, Structural and Environmental
More informationACCURACY AND EFFICIENCY OF MONTE CARLO METHOD. Julius Goodman. Bechtel Power Corporation E. Imperial Hwy. Norwalk, CA 90650, U.S.A.
- 430 - ACCURACY AND EFFICIENCY OF MONTE CARLO METHOD Julius Goodman Bechtel Power Corporation 12400 E. Imperial Hwy. Norwalk, CA 90650, U.S.A. ABSTRACT The accuracy of Monte Carlo method of simulating
More informationPreliminary Lab Exercise Part 1 Calibration of Eppendorf Pipette
Preliminary Lab Exercise Part 1 Calibration of Eppendorf Pipette Pipettes allow transfer of accurately known volume of solution from one container to another. Volumetric or transfer pipettes deliver a
More informationThe results section of a clinicaltrials.gov file is divided into discrete parts, each of which includes nested series of data entry screens.
OVERVIEW The ClinicalTrials.gov Protocol Registration System (PRS) is a web-based tool developed for submitting clinical trials information to ClinicalTrials.gov. This document provides step-by-step instructions
More informationThe Bootstrap and Jackknife
The Bootstrap and Jackknife Summer 2017 Summer Institutes 249 Bootstrap & Jackknife Motivation In scientific research Interest often focuses upon the estimation of some unknown parameter, θ. The parameter
More informationCHAPTER 2 Modeling Distributions of Data
CHAPTER 2 Modeling Distributions of Data 2.2 Density Curves and Normal Distributions The Practice of Statistics, 5th Edition Starnes, Tabor, Yates, Moore Bedford Freeman Worth Publishers Density Curves
More informationTest requesting in EMIS Web using Sunquest ICE
GP ICE User Guide Test requesting in EMIS Web using Sunquest ICE 1 Placing a request... 3 1.1 Navigating around the test request screen...4 1.1.1 Panels and pages... 4 1.1.2 Selecting a test... 4 1.1.3
More information3 Graphical Displays of Data
3 Graphical Displays of Data Reading: SW Chapter 2, Sections 1-6 Summarizing and Displaying Qualitative Data The data below are from a study of thyroid cancer, using NMTR data. The investigators looked
More informationFrequently Asked Questions Updated 2006 (TRIM version 3.51) PREPARING DATA & RUNNING TRIM
Frequently Asked Questions Updated 2006 (TRIM version 3.51) PREPARING DATA & RUNNING TRIM * Which directories are used for input files and output files? See menu-item "Options" and page 22 in the manual.
More informationCHAPTER 2 Modeling Distributions of Data
CHAPTER 2 Modeling Distributions of Data 2.2 Density Curves and Normal Distributions The Practice of Statistics, 5th Edition Starnes, Tabor, Yates, Moore Bedford Freeman Worth Publishers Density Curves
More informationRetention time prediction with irt for scheduled MRM and SWATH MS
Retention time prediction with irt for scheduled MRM and SWATH MS EuPa course, 28.11.2013 Oliver Rinner, PhD CEO Biognosys Summary Why to schedule MRM acquisition? How to schedule? Prediction of retention
More informationData Mining with Oracle 10g using Clustering and Classification Algorithms Nhamo Mdzingwa September 25, 2005
Data Mining with Oracle 10g using Clustering and Classification Algorithms Nhamo Mdzingwa September 25, 2005 Abstract Deciding on which algorithm to use, in terms of which is the most effective and accurate
More informationQuantitative - One Population
Quantitative - One Population The Quantitative One Population VISA procedures allow the user to perform descriptive and inferential procedures for problems involving one population with quantitative (interval)
More informationUnit 7 Statistics. AFM Mrs. Valentine. 7.1 Samples and Surveys
Unit 7 Statistics AFM Mrs. Valentine 7.1 Samples and Surveys v Obj.: I will understand the different methods of sampling and studying data. I will be able to determine the type used in an example, and
More informationHarris: Quantitative Chemical Analysis, Eight Edition CHAPTER 05: QUALITY ASSURANCE AND CALIBRATION METHODS
Harris: Quantitative Chemical Analysis, Eight Edition CHAPTER 05: QUALITY ASSURANCE AND CALIBRATION METHODS 5-0. International Measurement Evaluation Program Sample: Pb in river water (blind sample) :
More informationStandard INT Dynamic Transfers
A. Introduction 1. Title: Dynamic Transfers 2. Number: INT-004-3 3. Purpose: To ensure Dynamic Schedules and Pseudo-Ties are communicated and accounted for appropriately in congestion management procedures.
More informationChapter 5. Track Geometry Data Analysis
Chapter Track Geometry Data Analysis This chapter explains how and why the data collected for the track geometry was manipulated. The results of these studies in the time and frequency domain are addressed.
More informationTo finish the current project and start a new project. File Open a text data
GGEbiplot version 5 In addition to being the most complete, most powerful, and most user-friendly software package for biplot analysis, GGEbiplot also has powerful components for on-the-fly data manipulation,
More informationpan-canadian Oncology Drug Review Stakeholder Feedback on a pcodr Expert Review Committee Initial Recommendation (Manufacturer)
pan-canadian Oncology Drug Review Stakeholder Feedback on a pcodr Expert Review Committee Initial Recommendation (Manufacturer) Blinatumomab (Blincyto) for Philadelphia chromosome positive Acute Lymphoblastic
More informationLab Activity #2- Statistics and Graphing
Lab Activity #2- Statistics and Graphing Graphical Representation of Data and the Use of Google Sheets : Scientists answer posed questions by performing experiments which provide information about a given
More informationExploring and Understanding Data Using R.
Exploring and Understanding Data Using R. Loading the data into an R data frame: variable
More informationGeology Geomath Estimating the coefficients of various Mathematical relationships in Geology
Geology 351 - Geomath Estimating the coefficients of various Mathematical relationships in Geology Throughout the semester you ve encountered a variety of mathematical relationships between various geologic
More informationBasic Statistical Terms and Definitions
I. Basics Basic Statistical Terms and Definitions Statistics is a collection of methods for planning experiments, and obtaining data. The data is then organized and summarized so that professionals can
More informationUnicel DxH 600 System
SETUP MODULES Setup Unicel DxH 600 System Troubleshooting System Overview Additional Topics This document is not intended to replace the information in your Instrument Instructions for Use Manual (IFU).
More informationWeek 7: The normal distribution and sample means
Week 7: The normal distribution and sample means Goals Visualize properties of the normal distribution. Learning the Tools Understand the Central Limit Theorem. Calculate sampling properties of sample
More informationIB Chemistry IA Checklist Design (D)
Taken from blogs.bethel.k12.or.us/aweyand/files/2010/11/ia-checklist.doc IB Chemistry IA Checklist Design (D) Aspect 1: Defining the problem and selecting variables Report has a title which clearly reflects
More information